<?xml-stylesheet type="text/xsl" href="viewnlm-v2.3.xsl"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Yonsei Med J</journal-id><journal-id journal-id-type="publisher-id">YMJ</journal-id><journal-title-group><journal-title>Yonsei Medical Journal</journal-title></journal-title-group><issn pub-type="ppub">0513-5796</issn><issn pub-type="epub">1976-2437</issn><publisher><publisher-name>Yonsei University College of Medicine</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19259343</article-id><article-id pub-id-type="pmc">2649871</article-id><article-id pub-id-type="doi">10.3349/ymj.2009.50.1.12</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Intracellular Bacterial Infection and Invariant NKT Cells</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Emoto</surname><given-names>Masashi</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Emoto</surname><given-names>Yoshiko</given-names></name><xref ref-type="aff" rid="A1"/></contrib></contrib-group><aff id="A1">Laboratory of Immunology, Department of Laboratory Sciences, Gunma University School of Health Sciences, Maebashi, Gunma, Japan.</aff><author-notes><corresp>Reprint address: requests to Dr. Masashi Emoto, Laboratory of Immunology, Department of Laboratory Sciences, Gunma University School of Health Sciences, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan. Tel: 81-27-220-8935, Fax: 81-27-220-8935, <email>memoto@health.gunma-u.ac.jp</email></corresp></author-notes><pub-date pub-type="ppub"><day>28</day><month>2</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>24</day><month>2</month><year>2009</year></pub-date><volume>50</volume><issue>1</issue><fpage>12</fpage><lpage>21</lpage><history><date date-type="received"><day>04</day><month>11</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 The Yonsei University College of Medicine</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>The invariant (i) natural killer (NK)T cells represent a unique subset of T lymphocytes which express the V&#x003b1;14 chain of the T cell receptor (TCR), that recognizes glycolipid antigens presented by the nonpolymorphic major histocompatibility complex (MHC) class I-like antigen presentation molecule CD1d, and they participate in protection against some microbial pathogens. Although iNKT cells have originally been regarded as T cells co-expressing NKR-P1B/C (NK1.1: CD 161), they do not seem to consistently express this marker, since NK1.1 surface expression on iNKT cells undergoes dramatic changes following facultative intracellular bacterial infection, which is correlated with functional changes of this cell population. Accumulating evidence suggests that NK1.1 allows recognition of "missing-self", thus controling activation/inhibition of NK1.1-expressing cells. Therefore, it is tempting to suggest that iNKT cells participate in the regulation of host immune responses during facultative intracellular bacterial infection by controlling NK1.1 surface expression. These findings shed light not only on the unique role of iNKT cells in microbial infection, but also provide evidence for new aspects of the NK1.1 as a regulatory molecule on these cells.</p></abstract><kwd-group><kwd>Natural killer T cell</kwd><kwd>natural killer 1.1</kwd><kwd>NKR-P1</kwd><kwd>intracellular bacteria</kwd><kwd>liver</kwd><kwd><italic>Listeria monocytogenes</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Facultative intracellular bacteria comprise various pathogens such as <italic>Mycobacterium tuberculosis</italic>, <italic>M. leprae</italic>, <italic>Salmonella enterica</italic>, <italic>Brucella sp.</italic>, <italic>Legionella sp.</italic>, <italic>Listeria monocytogenes</italic>, and <italic>Francisella tularensis</italic>, all of which can survive in professional phagocytes such as macrophages.<xref ref-type="bibr" rid="B1">1</xref> Although innate immunity orchestrated by multiple cell populations, including granulocytes and macrophages, is pivotal for the elimination of these bacteria, conventional T cells are mandatory for sterile eradication of these pathogens (<xref ref-type="fig" rid="F1">Fig. 1</xref>).<xref ref-type="bibr" rid="B1">1</xref> Because the majority of facultative intracellular bacteria are trapped in the liver immediately after systemic infection, T cells that reside in and/or infiltrate the liver should play a decisive role in the following course of infection (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Experimental murine listeriosis models are instrumental in analyzing the role of T cells in the liver during facultative intracellular bacterial infection, not only because protection against <italic>L. monocytogenes</italic> strictly depends on T cells, but also because liver parenchymal cells serve as a reservoir for this bacterium (<xref ref-type="fig" rid="F1">Fig. 1</xref>).<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref></p><p>The liver is a rich provenance of unconventional T cells, called natural killer (NK)T cells, co-expressing NKR-P1B/C (NK1.1)(CD161) that are type II membrane glycoproteins of the C-type lectin superfamily.<xref ref-type="bibr" rid="B4">4</xref> The majority of NKT cells express an invariant (i) T cell receptor (TCR), typically comprising V&#x003b1;14/J&#x003b1;18 combined with a highly skewed TCRV&#x003b2; towards V&#x003b2;8.2 in mouse, and homologous chain V&#x003b1;24/J&#x003b1;18 paired with V&#x003b2;11 in human (iNKT cells).<xref ref-type="bibr" rid="B4">4</xref> The liver iNKT cells have a great potential to secrete both type 1 and type 2 cytokines.<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B7">7</xref> The high abundance of iNKT cells in the liver and their rapid and vigorous cytokine release in response to stimuli suggest participation of this cell population as an immunomodulator in the liver.</p><p>iNKT cells have been shown to participate in the regulation of various immune responses; e.g. tumor rejection<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref> and prevention of the development of autoimmune diseases.<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B12">12</xref> Although iNKT cells have been suggested to participate in elimination of various microbial pathogens,<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B26">26</xref> recent studies argue against the crucial role of this cell population in some microbial infections.<xref ref-type="bibr" rid="B27">27</xref>-<xref ref-type="bibr" rid="B32">32</xref> Moreover, new studies have shed light on the intriguing aspects of the NKR-P1 family, including NKR-P1B/C (NK1.1), in controlling immune responses.<xref ref-type="bibr" rid="B33">33</xref>-<xref ref-type="bibr" rid="B40">40</xref> Thus, iNKT cells appear to play more complicated roles than originally thought. Here, we focus on the unique aspects of iNKT cells as regulatory cells during murine listeriosis and the role of NK1.1 expressed on these cells.</p><sec><title>Is NK1.1 a reliable marker for iNKT cells?</title><p>Although iNKT cells were originally regarded as T cells co-expressing NK1.1, this cell population does not seem to consistently express this marker.<xref ref-type="bibr" rid="B41">41</xref>-<xref ref-type="bibr" rid="B44">44</xref> Immature iNKT cells lack surface expression of NK1.1, but they acquire the marker expression during ontogeny, suggesting that the NK1.1<sup>-</sup> subset is a precursor of NK1.1<sup>+</sup> subpopulation.<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref> Yet, substantial numbers of iNKT cells lacking NK1.1 have been identified in the periphery.<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref> This suggests that NK1.1 is not merely a marker for mature iNKT cells and raises the possibility that NK1.1 surface expression on iNKT cells is fluctuated under various conditions.</p><p>iNKT cells become undetectable upon activation.<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B45">45</xref>-<xref ref-type="bibr" rid="B61">61</xref> Although the disappearance of iNKT cells had been considered to be caused by activation-induced cell death/apoptosis (<xref ref-type="fig" rid="F2">Fig. 2A</xref>),<xref ref-type="bibr" rid="B48">48</xref>,<xref ref-type="bibr" rid="B51">51</xref>,<xref ref-type="bibr" rid="B53">53</xref>,<xref ref-type="bibr" rid="B61">61</xref> recent studies suggest that iNKT cells robustly expand <italic>in situ</italic> rather than undergoing apoptosis.<xref ref-type="bibr" rid="B57">57</xref>-<xref ref-type="bibr" rid="B59">59</xref>: i.e. the failure of iNKT cell detection is caused by the loss of NK1.1 and TCR, which were previously considered reliable markers for the detection of iNKT cells (<xref ref-type="fig" rid="F2">Fig. 2A</xref>).<xref ref-type="bibr" rid="B57">57</xref>-<xref ref-type="bibr" rid="B59">59</xref> Yet, the loss of surface expression of NK1.1 and TCR, and subsequent re-expression of marker(s) have thus far been observed only in iNKT cells stimulated with their agonist, &#x003b1;-galactoceramide (&#x003b1;-GalCer).<xref ref-type="bibr" rid="B57">57</xref>-<xref ref-type="bibr" rid="B59">59</xref></p></sec><sec><title>Fluctuation of liver iNKT cells during <italic>L. monocytogenes</italic> infection</title><p>Cells stained with monoclonal antibodies (mAbs) against surface markers, including NK1.1 and TCR, become transiently undetectable in the liver of mice following <italic>L. monocytogenes</italic> infection.<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B46">46</xref> This dynamic fluctuation of iNKT cells during <italic>L. monocytogenes</italic> infection has recently been verified using &#x003b1;-GalCer-loaded CD1d tetramers (&#x003b1;-GalCer/CD1d tetramers): the numbers of &#x003b1;-GalCer/CD1d tetramer-reactive T cells co-expressing NK1.1 (NK1.1<sup>+</sup> iNKT cells) are markedly reduced in the liver during the early stages of <italic>L. monocytogenes</italic> infection, whereas those of &#x003b1;-GalCer/CD1d tetramer-reactive T cells lacking NK1.1 (NK 1.1<sup>-</sup> iNKT cells) rise following infection and become dominant among the iNKT cell population (<xref ref-type="fig" rid="F2">Fig. 2B</xref>).<xref ref-type="bibr" rid="B28">28</xref> Similar kinetics of iNKT cells are seen in V&#x003b2;<sup>a</sup> mice, which are devoid of iNKT cells expressing TCRV&#x003b2;8,<xref ref-type="bibr" rid="B28">28</xref> implying that the curtailment of the NK1.1<sup>+</sup> subset and subsequent expansion of NK 1.1<sup>-</sup> subpopulation occur independently from TCRV&#x003b2; usage. Hence, iNKT cells are markedly influenced by <italic>L. monocytogenes</italic> infection, and the NK1.1<sup>+</sup> and NK1.1<sup>-</sup> subsets of iNKT cells show differential kinetics during listeriosis.</p></sec><sec><title>Participation of endogenous interleukin-12 in fluctuation of liver iNKT cells during <italic>L. monocytogenes</italic> infection</title><p>Interleukin (IL)-12 secreted mainly from macrophages, dendritic cells, and granulocytes is a heterodimeric cytokine which is composed of a covalently linked 35-kDa light chain (p35) and a 40-kDa heavy chain (p40).<xref ref-type="bibr" rid="B62">62</xref> IL-12 stimulates type 1 immune effector functions (e.g. promotion of IFN&#x003b3; secretion from Th1 cells and NK cells),<xref ref-type="bibr" rid="B62">62</xref> and hence, are mandatory for protection against intracellular microorganisms including <italic>L. monocytogenes</italic>.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B63">63</xref></p><p>Neutralization of endogenous IL-12 (p40) reverses the curtailment of the NK1.1<sup>+</sup> subset and the subsequent expansion of the NK1.1<sup>-</sup> subpopulation of iNKT cells during listeriosis.<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B46">46</xref> The kinetics of NK1.1<sup>+</sup> and NK1.1<sup>-</sup> iNKT cells in the liver following <italic>L. monocytogenes</italic> infection is paralleled by numerical changes of IL-12 producers in the liver.<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B64">64</xref>,<xref ref-type="bibr" rid="B65">65</xref> It is thus conceivable that fluctuation of iNKT cells during listeriosis is determined by IL-12 (p40) levels in the hepatic microenvironment.</p><p>Although IL-12 (p40) had been considered a useful tool for determination of the role of IL-12 <italic>in vivo</italic>, the p40 subunit of IL-12 has been demonstrated to be shared by IL-23, a cytokine which is a disulfide-bridged complex of a p19 subunit and the p40 subunit of IL-12.<xref ref-type="bibr" rid="B62">62</xref>,<xref ref-type="bibr" rid="B66">66</xref> It is therefore possible that IL-23 rather than IL-12 participates in the fluctuation of iNKT cells during <italic>L. monocytogenes</italic> infection. Yet, similarly to <italic>L. monocytogenes</italic> infection, numbers of NK1.1<sup>+</sup> subset are markedly diminished following <italic>in vivo</italic> administration of recombinant (r)IL-12, and the NK1.1<sup>-</sup> subpopulation expands thereafter (<xref ref-type="fig" rid="F2">Fig. 2B</xref>).<xref ref-type="bibr" rid="B28">28</xref> Thus, it is tempting to assume that endogenous IL-12 plays a central role in the fluctuation of iNKT cells during listeriosis, although it cannot completely be excluded that IL-23 also, at least in part, participates in this mechanism.</p></sec><sec><title>Fluctuation of iNKT cells is differentially controlled by signaling through TCR and IL-12R</title><p>iNKT cells become undetectable after stimulation with their agonist, &#x003b1;-GalCer.<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B49">49</xref>,<xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B54">54</xref>,<xref ref-type="bibr" rid="B56">56</xref>-<xref ref-type="bibr" rid="B59">59</xref> In contrast to <italic>L. monocytogenes</italic> infection, this change is not prevented by IL-12 neutralization (<xref ref-type="fig" rid="F2">Fig. 2A</xref>).<xref ref-type="bibr" rid="B64">64</xref> Thus, endogenous IL-12 is involved in the disappearance of NK1.1<sup>+</sup> iNKT cells during <italic>L. monocytogenes</italic> infection (<xref ref-type="fig" rid="F2">Fig. 2B</xref>),<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B46">46</xref> whereas the disappearance of NK1.1<sup>+</sup> iNKT cells by &#x003b1;-GalCer treatment apparently occurs independently from IL-12 (<xref ref-type="fig" rid="F2">Fig. 2A</xref>).<xref ref-type="bibr" rid="B64">64</xref></p><p>The TCR surface expression on iNKT cells is down-modulated after &#x003b1;-GalCer stimulation (<xref ref-type="fig" rid="F2">Fig. 2A</xref>),<xref ref-type="bibr" rid="B57">57</xref>-<xref ref-type="bibr" rid="B59">59</xref> whereas that on iNKT cells is not affected by <italic>Salmonella</italic> infection.<xref ref-type="bibr" rid="B58">58</xref> Similar to <italic>L. monocytogenes</italic> infection, fluctuation of iNKT cells during salmonellosis is also controlled by endogenous IL-12 [Emoto, unpublished observation]. It is therefore assumed that disappearance of NK1.1<sup>+</sup> subset and subsequent expansion of NK1.1<sup>-</sup> subpopulation are differentially controlled by signalling though TCR and IL-12R.</p></sec><sec><title>Origin of NK1.1<sup>-</sup> iNKT cells which emerge in the livers of mice following <italic>L. monocytogenes</italic> infection</title><p>The numerical increase of liver NK1.1<sup>-</sup> iNKT cells after <italic>L. monocytogenes</italic> infection is prevented by NK1.1<sup>+</sup> cell depletion.<xref ref-type="bibr" rid="B28">28</xref> This suggests that NK1.1<sup>+</sup> cells are a prerequisite for the emergence of NK1.1<sup>-</sup> iNKT cells. Because NK1.1<sup>+</sup> cells comprise not only iNKT cells, but also NK cells, it is possible that the numerical increase of NK1.1<sup>-</sup> iNKT cells following <italic>L. monocytogenes</italic> infection is controlled by NK cells. However, because numerical increase of NK1.1<sup>-</sup> iNKT cells following <italic>L. monocytogenes</italic> infection is further increased by NK cell depletion (anti-asialo GM1 Ab treatment),<xref ref-type="bibr" rid="B28">28</xref> this possibility is unlikely.</p><p>In addition to NK and iNKT cells, NK1.1<sup>+</sup> cells comprise nonclassical NKT cells. Although iNKT cells comprise cells expressing CD4 but lacking CD8 (CD4<sup>+</sup> cells), and those lacking CD4 and CD8 (CD4<sup>-</sup>8<sup>-</sup> (double negative: DN) cells), a small but distinct NKT cell population expressing CD8 has been identified.<xref ref-type="bibr" rid="B67">67</xref>-<xref ref-type="bibr" rid="B71">71</xref> Moreover, in contrast to iNKT cells which express TCR&#x003b1;/&#x003b2; as an antigen receptor, some NKT cells expressing TCR&#x003b3;/&#x003b4; have also been identified.<xref ref-type="bibr" rid="B70">70</xref>,<xref ref-type="bibr" rid="B72">72</xref>-<xref ref-type="bibr" rid="B75">75</xref> Because both cell populations are also abundant in the liver<xref ref-type="bibr" rid="B70">70</xref>,<xref ref-type="bibr" rid="B75">75</xref> and are depleted by NK1.1<sup>+</sup> cell depletion, it is possible that the prevention of the emergence of NK1.1<sup>-</sup> iNKT cells by NK1.1<sup>+</sup> cell depletion is caused by the depletion of these cells. However, because numerical increase of liver NK1.1<sup>-</sup> iNKT cells following <italic>L. monocytogenes</italic> infection is not prevented by CD8&#x003b1;<sup>+</sup> or TCR&#x003b3;/&#x003b4;<sup>+</sup> cell depletion,<xref ref-type="bibr" rid="B28">28</xref> this possibility is also unlikely. Thus, the NK1.1<sup>-</sup> subset, which emerges in the liver of <italic>L. monocytogenes</italic>-infected mice, is primarily derived from the NK1.1<sup>+</sup> subpopulation of iNKT cells.</p></sec><sec><title>Do iNKT cells propagate <italic>in situ</italic> following <italic>L. monocytogenes</italic> infection?</title><p>Recent studies suggest that iNKT cells expand <italic>in situ</italic> robustly in response to &#x003b1;-GalCer.<xref ref-type="bibr" rid="B57">57</xref>-<xref ref-type="bibr" rid="B59">59</xref> It is possible that a similar mechanism exists in listerial infection, because total numbers of iNKT cells are increased, though transiently reduced, following <italic>L. monocytogenes</italic> infection compared to preinfection.<xref ref-type="bibr" rid="B28">28</xref> However, because (i) numbers of NK cells are increased in the liver following <italic>L. monocytogenes</italic> infection,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref> (ii) expansion of iNKT cells is impaired in the presence of NK cells,<xref ref-type="bibr" rid="B76">76</xref>,<xref ref-type="bibr" rid="B77">77</xref> and (iii) expansion of liver iNKT cells is promoted by NK cell depletion, which is caused by increased local concentrations of IL-15<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B76">76</xref> (IL-15 is prerequisite for the proliferation of not only NK cells but also iNKT cells<xref ref-type="bibr" rid="B78">78</xref>), it is conceivable that iNKT cells increased in the liver following <italic>L. monocytogenes</italic> infection are supplied from other organs. Hence, it is likely that stimulation by a specific antigen (i.e. &#x003b1;-GalCer) and by the cytokine IL-12 have differential outcomes.</p></sec><sec><title>Infiltration of iNKT cells in the liver following <italic>L. monocytogenes</italic> infection occurs independently from thymus</title><p>Although thymus is essential for the development of iNKT cells (<xref ref-type="fig" rid="F3">Fig. 3</xref>),<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B70">70</xref>,<xref ref-type="bibr" rid="B79">79</xref>-<xref ref-type="bibr" rid="B81">81</xref> comparable numbers of those cells are detected in adult thymectomized mice.<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B82">82</xref> Similar to euthymic mice, numbers of the NK1.1<sup>+</sup> subset are markedly diminished in adult thymectomized mice following <italic>L. monocytogenes</italic> infection, and the NK1.1<sup>-</sup> subpopulation is numerically increased.<xref ref-type="bibr" rid="B28">28</xref> Thus, numerical alterations in NK1.1<sup>+</sup> and NK1.1<sup>-</sup> iNKT cell populations in response to <italic>L. monocytogenes</italic> infection occur independently from a functional thymus. The NK1.1<sup>+</sup> subset in the periphery has been found to be derived from a thymic NK1.1<sup>-</sup> subpopulation of iNKT cells.<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref> In this study, NK1.1 surface expression on iNKT cells is acquired in the periphery after the cells have left the thymus during ontogeny. However, the NK1.1<sup>-</sup> subset that emerges in the liver following <italic>L. monocytogenes</italic> infection develops from the NK1.1<sup>+</sup> subpopulation of iNKT cells.<xref ref-type="bibr" rid="B28">28</xref> Because the disappearance of liver iNKT cells after TCR stimulation has been shown to be followed by repopulation of these cells due to homeostatic proliferation of an iNKT-cell reservoir in the bone marrow,<xref ref-type="bibr" rid="B48">48</xref> it is conceivable that some NK1.1<sup>+</sup> iNKT cells, which re-emerge at later stages of listeriosis, are derived from the bone marrow, although <italic>in situ</italic> expansion of iNKT cells cannot completely be excluded (<xref ref-type="fig" rid="F3">Fig. 3</xref>). Hence, accumulation of iNKT cells in the liver is differentially regulated under physiological and inflammatory conditions.<xref ref-type="bibr" rid="B48">48</xref></p></sec><sec><title>Functional alterations of liver iNKT cells during listeriosis</title><p>Substantial numbers of IFN-&#x003b3; and IL-4 producers are detected among liver iNKT cells from uninfected mice after <italic>in vitro</italic> stimulation with TCR/CD3 ligation<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref> or with phorbol myristate acetate and ionomycine<xref ref-type="bibr" rid="B28">28</xref> (<xref ref-type="fig" rid="F4">Fig. 4</xref>). High numbers of IFN-&#x003b3; producers are detected among liver iNKT cells from <italic>L. monocytogenes</italic>-infected mice, whereas IL-4-producing cells are virtually undetectable (<xref ref-type="fig" rid="F4">Fig. 4</xref>).<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B46">46</xref> Because the vast majority of iNKT cells in the liver of <italic>L. monocytogenes</italic>-infected mice lack surface expression of NK1.1, these findings suggest that NK1.1<sup>-</sup> iNKT cells, which emerge in the <italic>L. monocytogenes</italic>-infected liver, fail to produce IL-4 and hence express a Th1-like phenotype.</p><p>In mouse, the iNKT cells segregate into 2 populations on the basis of CD4 expression; i.e. CD4<sup>+</sup> and DN cells.<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B83">83</xref> Before infection, the majority of liver iNKT cells co-express CD4 and only a minority lack this marker.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B28">28</xref> The CD4<sup>+</sup> iNKT cells are numerically reduced after <italic>L. monocytogenes</italic> infection, whereas DN iNKT cells are virtually unaffected (<xref ref-type="fig" rid="F4">Fig. 4</xref>).<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B46">46</xref> Hence, <italic>L. monocytogenes</italic> infection primarily compresses the CD4<sup>+</sup> rather than DN iNKT-cell population.</p><p>Since the CD4<sup>+</sup> and DN iNKT cells are differentially influenced by <italic>L. monocytogenes</italic> infection, it is possible that each cell subset plays a different role during <italic>L. monocytogenes</italic> infection. In uninfected mice, frequencies of IL-4-producing iNKT cells are markedly reduced by CD4<sup>+</sup> or NK1.1<sup>+</sup> cell depletion, whereas numbers of IFN-&#x003b3; producers are virtually unaffected.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B28">28</xref> In contrast, frequencies of IFN-&#x003b3;-producing iNKT cells are markedly higher in CD4<sup>+</sup> cell-depleted mice after infection as compared to nondepleted mice.<xref ref-type="bibr" rid="B28">28</xref> These findings suggest that NK1.1<sup>-</sup> iNKT cells with IFN-&#x003b3;-producing activity in the <italic>L. monocytogenes</italic>-infected liver are preferentially DN (<xref ref-type="fig" rid="F4">Fig. 4</xref>).</p><p>DN iNKT cells differ from CD4<sup>+</sup> iNKT cells in their cytokine production profile.<xref ref-type="bibr" rid="B69">69</xref>,<xref ref-type="bibr" rid="B84">84</xref>-<xref ref-type="bibr" rid="B88">88</xref> In general, CD4<sup>+</sup> rather than DN iNKT cells are responsible for IL-4 production albeit at varying levels in different organs. Since (i) CD4<sup>+</sup> cells dominate DN cells among liver iNKT cells,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B28">28</xref> (ii) IL-4-producing cells in the liver are markedly reduced by NK1.1<sup>+</sup> cell depletion,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B46">46</xref> (iii) large numbers of IL-4 producers are detected among purified liver CD4<sup>+</sup> NK1.1<sup>+</sup> cells after TCR ligation,<xref ref-type="bibr" rid="B6">6</xref> and (iv) numbers of IL-4-producing iNKT cells from CD4<sup>+</sup> or NK1.1<sup>+</sup> cell-depleted mice are minute,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B28">28</xref> it appears that the CD4<sup>+</sup>NK1.1<sup>+</sup> subset under physiological conditions is mainly responsible for IL-4 production in the liver although iNKT cells express both IL-4 and IFN-&#x003b3; mRNA upon stimulation.<xref ref-type="bibr" rid="B89">89</xref>,<xref ref-type="bibr" rid="B90">90</xref> Differential stimulation (i.e. specific antigen versus IL-12) is probably responsible for distinct cytokine production with inflammation, thus driving IFN-&#x003b3; production from iNKT cells.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B46">46</xref></p></sec><sec><title>NK1.1<sup>-</sup> iNKT cells re-express NK1.1 at later stages of listeriosis</title><p>Numbers of iNKT cells reach levels comparable to those in uninfected animals at later stages of listeriosis.<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B64">64</xref> In parallel, the NK1.1<sup>+</sup> subset is proportionally increased and NK1.1<sup>-</sup> subpopulation is reduced. It is thus possible that NK1.1 is re-expressed on iNKT cells even if the marker was lost. Substantial numbers of donor-derived NK1.1<sup>+</sup> iNKT cells are detected in the liver of recipient re-arrangement gene-1<sup>-/-</sup> mice lacking all T cells, including iNKT cells, which was reconstituted with NK1.1<sup>+</sup> cell-depleted hepatic leukocytes from mice that had been infected with <italic>L. monocytogenes</italic>.<xref ref-type="bibr" rid="B28">28</xref> These findings suggest that NK1.1 can be re-expressed on iNKT cells, even in spite of previous loss of the marker (<xref ref-type="fig" rid="F2">Fig. 2B</xref>), although it cannot completely be excluded that NK1.1<sup>-</sup> iNKT cells fail to accumulate in the liver of recipient mice. It is conceivable that at least NK1.1<sup>+</sup> iNKT cells, which re-emerge during late stages of listeriosis, express functional activities similar to those in naive mice, because NK1.1<sup>+</sup> iNKT cells that re-emerged in the liver have a potential to secrete IL-4.<xref ref-type="bibr" rid="B64">64</xref></p><p>Re-expression of NK1.1 on liver iNKT cells from mice, which had been infected with <italic>L. monocytogenes</italic>, is not found after <italic>in-vitro</italic> culture even in the presence of IL-12-neutralizing mAb [Emoto et al., unpublished observation]. This is consistent with previous findings showing that TCR, but not NK1.1, becomes detectable on &#x003b1;-GalCer-stimulated iNKT cells after <italic>in-vitro</italic> culture.<xref ref-type="bibr" rid="B58">58</xref> These findings suggest that different mechanisms exist in the disappearance/re-emergence of NK1.1 and TCR, and that some factor(s) other than IL-12 also participate in down-modulation of NK1.1 on iNKT cells.</p></sec><sec><title>Is down-modulation of NK1.1 on iNKT cells essential prerequisite for combat <italic>L. monocytogenes</italic>?</title><p>The NKR-P1 family comprises activatory and inhibitory receptors. Whereas NKR-P1A, NKR-P1C, and NKR-P1F are activatory receptors, NKR-P1B and NKR-P1D are inhibitory receptors.<xref ref-type="bibr" rid="B33">33</xref>-<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B91">91</xref> Lectin-like transcript 1 or C-type lectin-related molecules have been identified as ligands for NKR-P1A, NKR-P1B, NKR-P1D, and NKR-P1F.<xref ref-type="bibr" rid="B38">38</xref>-<xref ref-type="bibr" rid="B40">40</xref> Thus, NKR-P1 family members allow recognition of "missing-self", thus controlling activation/inhibition of NK1.1<sup>+</sup> cells in a MHC class I-independent manner. Because cross-linking of NKR-P1C by anti-NK1.1 mAb induces IFN-&#x003b3; production from NK1.1<sup>+</sup> cells,<xref ref-type="bibr" rid="B33">33</xref> it is possible that NKR-P1C participates in immunosurveillance such as the elimination of cells lacking hither-to-unknown antigen(s) expressed on infected cells (<xref ref-type="fig" rid="F5">Fig. 5</xref>). It is therefore possible that NK1.1 participates in surveillance of infection, and that the loss of NK1.1 counteracts excessive inflammatory responses.</p></sec><sec><title>Detrimental role of iNKT cells against <italic>L. monocytogenes</italic> infection</title><p>IFN-&#x003b3; plays an essential role in resistance against <italic>L. monocytogenes</italic> infection,<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B92">92</xref>-<xref ref-type="bibr" rid="B95">95</xref> whereas IL-4 exacerbates disease.<xref ref-type="bibr" rid="B96">96</xref>-<xref ref-type="bibr" rid="B99">99</xref> Since considerable numbers of IFN-&#x003b3;, but not IL-4-secreting iNKT cells, are found in the liver of <italic>L. monocytogenes</italic>-infected mice, it is possible that iNKT cells participate in protection against <italic>L. monocytogenes</italic> infection. Yet, J&#x003b1;18<sup>-/-</sup> mice, which are entirely devoid of iNKT cells, are more resistant to <italic>L. monocytogenes</italic> infection than control mice.<xref ref-type="bibr" rid="B28">28</xref> These findings suggest that iNKT cells do not participate in antilisterial resistance and may even exacerbate disease, although contribution of iNKT cells in protection against enteric listeriosis has been suggested.<xref ref-type="bibr" rid="B100">100</xref> Because iNKT cells comprise a heterogeneous population, it is speculated that the IFN-&#x003b3;-producing NK1.1<sup>-</sup> subset of iNKT cells ameliorates, whereas the IL4-producing NK1.1<sup>+</sup> subpopulation exacerbates disease (see <xref ref-type="fig" rid="F4">Fig. 4</xref>).</p><p>At first sight, the finding that listeriosis in mice lacking total iNKT cells is ameliorated could be taken as an argument against a pivotal role of the iNKT cells in protection against <italic>L. monocytogenes</italic> infection. However, 2 subsets of iNKT cells exist: (i) The CD4<sup>+</sup>NK1.1<sup>+</sup> subset which produces IL-4 and hence should be of detriment in listeriosis. At early stages of infection, exacerbation by this subset seems to dominate because depletion of the total iNKT cell population ameliorates listeriosis. This notion is consistent with previous findings showing that listeriosis is improved by anti-CD1 mAb treatment.<xref ref-type="bibr" rid="B29">29</xref> (ii) The CD4<sup>-</sup>NK1.1<sup>-</sup> subset produces IFN-&#x003b3; suggesting its beneficial role in listeriosis. Yet, contribution of the NK1.1<sup>-</sup> subset to resistance occurs later and seems supportive but not essential.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>NK1.1 surface expression and functional activities of iNKT cells are markedly influenced by listerial infection. Despite the designation of NKT cells, the NK1.1 surface molecule is not a reliable marker of this cell population. Although iNKT cells produce both IFN-&#x003b3; and IL-4 in naive mice, the majority of this cell population produces IFN-&#x003b3; during listeriosis, but not IL-4 due to abundant IL-12 in microenvironment. It is therefore tempting to assume that distinct iNKT-cell populations play different roles in intracellular bacterial infection. Of these, the NK1.1<sup>+</sup> subset seems ineffectual or even harmful, whereas the NK1.1<sup>-</sup> subset appears to contribute to antilisterial protection by means of IFN-&#x003b3;. NK1.1 surface expression on iNKT cells in the liver fluctuates during <italic>L. monocytogenes</italic> infection in a reversible manner. This dynamic fluctuation of NK1.1 expression on iNKT cells suggests a unique role of the NK1.1 molecule on this cell population during intracellular bacterial infection.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p>This work was supported by a Grant-in-Aid for Scientific Research (<award-id>17590383</award-id>) from the <funding-source>Japan Society for the Promotion of Science</funding-source>, The <funding-source>Waksman Foundation of Japan Inc.</funding-source>, The <funding-source>Japan Research Foundation for Clinical Pharmacology</funding-source>, <funding-source>Mishima Kaiun Memorial Foundation</funding-source>, <funding-source>Hokuto Foundation for Bioscience</funding-source>, and the <funding-source>German Science Foundation</funding-source> (<award-id>SFB 421</award-id>).</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Paul</surname><given-names>WE</given-names></name></person-group><article-title>Immunity to intracellular bacteria</article-title><source>Fundamental Immunology</source><year>2003</year><edition>5th ed</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Lippincott-Raven Publishers</publisher-name><fpage>1229</fpage><lpage>1261</lpage></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>North</surname><given-names>RJ</given-names></name><name><surname>Conlan</surname><given-names>JW</given-names></name></person-group><article-title>Immunity to <italic>Listeria monocytogenes</italic></article-title><source>Chem Immunol</source><year>1998</year><volume>70</volume><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">9509668</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gregory</surname><given-names>SH</given-names></name><name><surname>Wing</surname><given-names>EJ</given-names></name></person-group><article-title>Neutrophil-Kupffer-cell interaction in host defenses to systemic infections</article-title><source>Immunol Today</source><year>1998</year><volume>19</volume><fpage>507</fpage><lpage>510</lpage><pub-id pub-id-type="pmid">9818544</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emoto</surname><given-names>M</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><article-title>Liver NKT cells: an account of heterogeneity</article-title><source>Trends Immunol</source><year>2003</year><volume>24</volume><fpage>364</fpage><lpage>369</lpage><pub-id pub-id-type="pmid">12860526</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emoto</surname><given-names>M</given-names></name><name><surname>Emoto</surname><given-names>Y</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><article-title>IL-4 producing CD4<sup>+</sup> TCR&#x003b1;&#x003b2;<sup>int</sup> liver lymphocytes: influence of thymus, &#x003b2;<sub>2</sub>-microglobulin and NK1.1 expression</article-title><source>Int Immunol</source><year>1995</year><volume>7</volume><fpage>1729</fpage><lpage>1739</lpage><pub-id pub-id-type="pmid">8580071</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emoto</surname><given-names>M</given-names></name><name><surname>Emoto</surname><given-names>Y</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><article-title>Interleukin-4-producing CD4<sup>+</sup> NK1.1<sup>+</sup> TCR&#x003b1;&#x003b2;<sup>intermediate</sup> liver lymphocytes are down-regulated by <italic>Listeria monocytogenes</italic></article-title><source>Eur J Immunol</source><year>1995</year><volume>25</volume><fpage>3321</fpage><lpage>3325</lpage><pub-id pub-id-type="pmid">8566018</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emoto</surname><given-names>M</given-names></name><name><surname>Emoto</surname><given-names>Y</given-names></name><name><surname>Buchwalow</surname><given-names>IB</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><article-title>Induction of IFN-&#x003b3;-producing CD4<sup>+</sup> natural killer T cells by <italic>Mycobacterium bovis</italic> bacillus Calmette Gu&#x000e9;rin</article-title><source>Eur J Immunol</source><year>1999</year><volume>29</volume><fpage>650</fpage><lpage>659</lpage><pub-id pub-id-type="pmid">10064082</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>J</given-names></name><name><surname>Shin</surname><given-names>T</given-names></name><name><surname>Kawano</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>H</given-names></name><name><surname>Kondo</surname><given-names>E</given-names></name><name><surname>Toura</surname><given-names>I</given-names></name><etal/></person-group><article-title>Requirement for V&#x003b1;14 NKT cells in IL-12-mediated rejection of tumors</article-title><source>Science</source><year>1997</year><volume>278</volume><fpage>1623</fpage><lpage>1626</lpage><pub-id pub-id-type="pmid">9374462</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawano</surname><given-names>T</given-names></name><name><surname>Cui</surname><given-names>J</given-names></name><name><surname>Koezuka</surname><given-names>Y</given-names></name><name><surname>Toura</surname><given-names>I</given-names></name><name><surname>Kaneko</surname><given-names>Y</given-names></name><name><surname>Sato</surname><given-names>H</given-names></name><etal/></person-group><article-title>Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated V&#x003b1;14 NKT cells</article-title><source>Proc Natl Acad Sci U S A</source><year>1998</year><volume>95</volume><fpage>5690</fpage><lpage>5693</lpage><pub-id pub-id-type="pmid">9576945</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falcone</surname><given-names>M</given-names></name><name><surname>Yeung</surname><given-names>B</given-names></name><name><surname>Tucker</surname><given-names>L</given-names></name><name><surname>Rodriguez</surname><given-names>E</given-names></name><name><surname>Sarvetnick</surname><given-names>N</given-names></name></person-group><article-title>A defect in interleukin 12-induced activation and interferon &#x003b3; secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus</article-title><source>J Exp Med</source><year>1999</year><volume>190</volume><fpage>963</fpage><lpage>972</lpage><pub-id pub-id-type="pmid">10510086</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>K</given-names></name><name><surname>Miyake</surname><given-names>S</given-names></name><name><surname>Yamamura</surname><given-names>T</given-names></name></person-group><article-title>A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells</article-title><source>Nature</source><year>2001</year><volume>413</volume><fpage>531</fpage><lpage>534</lpage><pub-id pub-id-type="pmid">11586362</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>S</given-names></name><name><surname>Wilson</surname><given-names>MT</given-names></name><name><surname>Serizawa</surname><given-names>I</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Naidenko</surname><given-names>OV</given-names></name><etal/></person-group><article-title>The natural killer T-cell ligand &#x003b1;-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice</article-title><source>Nat Med</source><year>2001</year><volume>7</volume><fpage>1052</fpage><lpage>1056</lpage><pub-id pub-id-type="pmid">11533710</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denkers</surname><given-names>EY</given-names></name><name><surname>Scharton-Kerston</surname><given-names>T</given-names></name><name><surname>Barbieri</surname><given-names>S</given-names></name><name><surname>Caspar</surname><given-names>P</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name></person-group><article-title>A role for CD4<sup>+</sup>NK1.1<sup>+</sup> T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8<sup>+</sup> effector function against intracellular infection</article-title><source>J Exp Med</source><year>1996</year><volume>184</volume><fpage>131</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">8691126</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>H</given-names></name><name><surname>Hisaeda</surname><given-names>H</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Sakai</surname><given-names>T</given-names></name><name><surname>Maekawa</surname><given-names>Y</given-names></name><etal/></person-group><article-title>CD4<sup>+</sup> V&#x003b1;14 NKT cells play a crucial role in an early stage of protective immunity against infection with <italic>Leishmania major</italic></article-title><source>Int Immunol</source><year>2000</year><volume>12</volume><fpage>1267</fpage><lpage>1274</lpage><pub-id pub-id-type="pmid">10967021</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Aseguinolaza</surname><given-names>G</given-names></name><name><surname>de Oliveira</surname><given-names>C</given-names></name><name><surname>Tomaska</surname><given-names>M</given-names></name><name><surname>Hong</surname><given-names>S</given-names></name><name><surname>Bruna-Romero</surname><given-names>O</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><etal/></person-group><article-title>&#x003b1;-galactosylceramide-activated V&#x003b1;14 natural killer T cells mediate protection against murine malaria</article-title><source>Proc Natl Acad Sci U S A</source><year>2000</year><volume>97</volume><fpage>8461</fpage><lpage>8466</lpage><pub-id pub-id-type="pmid">10900007</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawakami</surname><given-names>K</given-names></name><name><surname>Kinjo</surname><given-names>Y</given-names></name><name><surname>Yara</surname><given-names>S</given-names></name><name><surname>Koguchi</surname><given-names>Y</given-names></name><name><surname>Uezu</surname><given-names>K</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><etal/></person-group><article-title>Activation of V&#x003b1;14<sup>+</sup> natural killer T cells by &#x003b1;-galactosylceramide results in development of Th1 response and local host resistance in mice infected with <italic>Cryptococcus neoformans</italic></article-title><source>Infect Immun</source><year>2001</year><volume>69</volume><fpage>213</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">11119508</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Exley</surname><given-names>MA</given-names></name><name><surname>Bigley</surname><given-names>NJ</given-names></name><name><surname>Cheng</surname><given-names>O</given-names></name><name><surname>Tahir</surname><given-names>SM</given-names></name><name><surname>Smiley</surname><given-names>ST</given-names></name><name><surname>Carter</surname><given-names>QL</given-names></name><etal/></person-group><article-title>CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus</article-title><source>J Leukoc Biol</source><year>2001</year><volume>69</volume><fpage>713</fpage><lpage>718</lpage><pub-id pub-id-type="pmid">11358978</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duthie</surname><given-names>MS</given-names></name><name><surname>Wleklinski-Lee</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>S</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Kahn</surname><given-names>SJ</given-names></name></person-group><article-title>During <italic>Trypanosoma cruzi</italic> infection CD1-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein</article-title><source>Infect Immun</source><year>2002</year><volume>70</volume><fpage>36</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">11748161</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>TR</given-names></name><name><surname>Hong</surname><given-names>S</given-names></name><name><surname>van Kaer</surname><given-names>L</given-names></name><name><surname>Koezuka</surname><given-names>Y</given-names></name><name><surname>Graham</surname><given-names>BS</given-names></name></person-group><article-title>NK T cells contribute to expansion of CD8<sup>+</sup> T cells and amplification of antiviral immune responses to respiratory syncytial virus</article-title><source>J Virol</source><year>2002</year><volume>76</volume><fpage>4294</fpage><lpage>4303</lpage><pub-id pub-id-type="pmid">11932395</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieuwenhuis</surname><given-names>EE</given-names></name><name><surname>Matsumoto</surname><given-names>T</given-names></name><name><surname>Exley</surname><given-names>M</given-names></name><name><surname>Schleipman</surname><given-names>RA</given-names></name><name><surname>Glickman</surname><given-names>J</given-names></name><name><surname>Bailey</surname><given-names>DT</given-names></name><etal/></person-group><article-title>CD1d-dependent macrophage-mediated clearance of <italic>Pseudomonas aeruginosa</italic> from lung</article-title><source>Nat Med</source><year>2002</year><volume>8</volume><fpage>588</fpage><lpage>593</lpage><pub-id pub-id-type="pmid">12042809</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brigl</surname><given-names>M</given-names></name><name><surname>Bry</surname><given-names>L</given-names></name><name><surname>Kent</surname><given-names>SC</given-names></name><name><surname>Gumperz</surname><given-names>JE</given-names></name><name><surname>Brenner</surname><given-names>MB</given-names></name></person-group><article-title>Mechanism of CD1d-restricted natural killer T cell activation during microbial infection</article-title><source>Nat Immunol</source><year>2003</year><volume>4</volume><fpage>1230</fpage><lpage>1237</lpage><pub-id pub-id-type="pmid">14578883</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grubor-Bauk</surname><given-names>B</given-names></name><name><surname>Simmons</surname><given-names>A</given-names></name><name><surname>Mayrhofer</surname><given-names>G</given-names></name><name><surname>Speck</surname><given-names>PG</given-names></name></person-group><article-title>Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V&#x003b1;14-J&#x003b1;281 TCR</article-title><source>J Immunol</source><year>2003</year><volume>170</volume><fpage>1430</fpage><lpage>1434</lpage><pub-id pub-id-type="pmid">12538704</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawakami</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>N</given-names></name><name><surname>Kinjo</surname><given-names>Y</given-names></name><name><surname>Miyagi</surname><given-names>K</given-names></name><name><surname>Nakasone</surname><given-names>C</given-names></name><name><surname>Uezu</surname><given-names>K</given-names></name><etal/></person-group><article-title>Critical role of V&#x003b1;14<sup>+</sup> natural killer T cells in the innate phase of host protection against <italic>Streptococcus pneumoniae</italic> infection</article-title><source>Eur J Immunol</source><year>2003</year><volume>33</volume><fpage>3322</fpage><lpage>3330</lpage><pub-id pub-id-type="pmid">14635040</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amprey</surname><given-names>JL</given-names></name><name><surname>Im</surname><given-names>JS</given-names></name><name><surname>Turco</surname><given-names>SJ</given-names></name><name><surname>Murray</surname><given-names>HW</given-names></name><name><surname>Illarionov</surname><given-names>PA</given-names></name><name><surname>Besra</surname><given-names>GS</given-names></name><etal/></person-group><article-title>A subset of liver NK T cells is activated during <italic>Leishmania donovani</italic> infection by CD1d-bound lipophosphoglycan</article-title><source>J Exp Med</source><year>2004</year><volume>200</volume><fpage>895</fpage><lpage>904</lpage><pub-id pub-id-type="pmid">15466622</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smiley</surname><given-names>ST</given-names></name><name><surname>Lanthier</surname><given-names>PA</given-names></name><name><surname>Couper</surname><given-names>KN</given-names></name><name><surname>Szaba</surname><given-names>FM</given-names></name><name><surname>Boyson</surname><given-names>JE</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><etal/></person-group><article-title>Exacerbated susceptibility to infection-stimulated immunopathology in CD1d-deficient mice</article-title><source>J Immunol</source><year>2005</year><volume>174</volume><fpage>7904</fpage><lpage>7911</lpage><pub-id pub-id-type="pmid">15944296</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behar</surname><given-names>SM</given-names></name><name><surname>Dascher</surname><given-names>CC</given-names></name><name><surname>Grusby</surname><given-names>MJ</given-names></name><name><surname>Wang</surname><given-names>CR</given-names></name><name><surname>Brenner</surname><given-names>MB</given-names></name></person-group><article-title>Susceptibility of mice deficient in CD1D or TAP1 to infection with <italic>Mycobacterium tuberculosis</italic></article-title><source>J Exp Med</source><year>1999</year><volume>189</volume><fpage>1973</fpage><lpage>1980</lpage><pub-id pub-id-type="pmid">10377193</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teixeira</surname><given-names>HC</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><article-title>Role of NK1.1<sup>+</sup> cells in experimental listeriosis. NK1<sup>+</sup> cells are early IFN-&#x003b3; producers but impair resistance to <italic>Listeria monocytogenes</italic> infection</article-title><source>J Immunol</source><year>1994</year><volume>152</volume><fpage>1873</fpage><lpage>1882</lpage><pub-id pub-id-type="pmid">8120395</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emoto</surname><given-names>M</given-names></name><name><surname>Yoshizawa</surname><given-names>I</given-names></name><name><surname>Emoto</surname><given-names>Y</given-names></name><name><surname>Miamoto</surname><given-names>M</given-names></name><name><surname>Hurwitz</surname><given-names>R</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><article-title>Rapid development of a gamma interferon-secreting glycolipid/CD1d-specific V&#x003b1;14<sup>+</sup>NK 1.1<sup>-</sup> T-cell subset after bacterial infection</article-title><source>Infect Immun</source><year>2006</year><volume>74</volume><fpage>5903</fpage><lpage>5913</lpage><pub-id pub-id-type="pmid">16988270</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szalay</surname><given-names>G</given-names></name><name><surname>Ladel</surname><given-names>CH</given-names></name><name><surname>Blum</surname><given-names>C</given-names></name><name><surname>Brossay</surname><given-names>L</given-names></name><name><surname>Kronenberg</surname><given-names>M</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><article-title>Cutting edge: anti-CD1 monoclonal antibody treatment reverses the production patterns of TGF-&#x003b2;2 and Th1 cytokines and ameliorates listeriosis in mice</article-title><source>J Immunol</source><year>1999</year><volume>162</volume><fpage>6955</fpage><lpage>6958</lpage><pub-id pub-id-type="pmid">10358132</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawakami</surname><given-names>K</given-names></name><name><surname>Kinjo</surname><given-names>Y</given-names></name><name><surname>Uezu</surname><given-names>K</given-names></name><name><surname>Yara</surname><given-names>S</given-names></name><name><surname>Miyagi</surname><given-names>K</given-names></name><name><surname>Koguchi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Minimal contribution of V&#x003b1;14 natural killer T cells to Th1 response and host resistance against mycobacterial infection in mice</article-title><source>Microbiol Immunol</source><year>2002</year><volume>46</volume><fpage>207</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">12008930</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilenki</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Joyee</surname><given-names>AG</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name></person-group><article-title>NK T cell activation promotes <italic>Chlamydia trachomatis</italic> infection <italic>in vivo</italic></article-title><source>J Immunol</source><year>2005</year><volume>175</volume><fpage>3197</fpage><lpage>3206</lpage><pub-id pub-id-type="pmid">16116210</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornish</surname><given-names>AL</given-names></name><name><surname>Keating</surname><given-names>R</given-names></name><name><surname>Kyparissoudis</surname><given-names>K</given-names></name><name><surname>Smyth</surname><given-names>MJ</given-names></name><name><surname>Carbone</surname><given-names>FR</given-names></name><name><surname>Godfrey</surname><given-names>DI</given-names></name></person-group><article-title>NKT cells are not critical for HSV-1 disease resolution</article-title><source>Immunol Cell Biol</source><year>2006</year><volume>84</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">16277640</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arase</surname><given-names>H</given-names></name><name><surname>Arase</surname><given-names>N</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name></person-group><article-title>Interferon &#x003b3; production by natural killer (NK) cells and NK1.1<sup>+</sup> T cells upon NKR-P1 cross-linking</article-title><source>J Exp Med</source><year>1996</year><volume>183</volume><fpage>2391</fpage><lpage>2396</lpage><pub-id pub-id-type="pmid">8642351</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arase</surname><given-names>N</given-names></name><name><surname>Arase</surname><given-names>H</given-names></name><name><surname>Park</surname><given-names>SY</given-names></name><name><surname>Ohno</surname><given-names>H</given-names></name><name><surname>Ra</surname><given-names>C</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name></person-group><article-title>Association with FcR&#x003b3; is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1.1<sup>+</sup> T cells</article-title><source>J Exp Med</source><year>1997</year><volume>186</volume><fpage>1957</fpage><lpage>1963</lpage><pub-id pub-id-type="pmid">9396764</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>JC</given-names></name><name><surname>Seaman</surname><given-names>WE</given-names></name></person-group><article-title>Divergent functions of lectin-like receptors on NK cells</article-title><source>Immunol Rev</source><year>1997</year><volume>155</volume><fpage>79</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">9059884</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlyle</surname><given-names>JR</given-names></name><name><surname>Martin</surname><given-names>A</given-names></name><name><surname>Mehra</surname><given-names>A</given-names></name><name><surname>Attisano</surname><given-names>L</given-names></name><name><surname>Tsui</surname><given-names>FW</given-names></name><name><surname>Z&#x000fa;&#x000f1;iga-Pfl&#x000fc;cker</surname><given-names>JC</given-names></name></person-group><article-title>Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function</article-title><source>J Immunol</source><year>1999</year><volume>162</volume><fpage>5917</fpage><lpage>5923</lpage><pub-id pub-id-type="pmid">10229828</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kung</surname><given-names>SK</given-names></name><name><surname>Su</surname><given-names>RC</given-names></name><name><surname>Shannon</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>RG</given-names></name></person-group><article-title>The NKR-P1B gene product is an inhibitory receptor on SJL/J NK cells</article-title><source>J Immunol</source><year>1999</year><volume>162</volume><fpage>5876</fpage><lpage>5887</lpage><pub-id pub-id-type="pmid">10229823</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iizuka</surname><given-names>K</given-names></name><name><surname>Naidenko</surname><given-names>OV</given-names></name><name><surname>Plougastel</surname><given-names>BF</given-names></name><name><surname>Fremont</surname><given-names>DH</given-names></name><name><surname>Yokoyama</surname><given-names>WM</given-names></name></person-group><article-title>Genetically linked C-type lectin-related ligands for the NKR-P1 family of natural killer cell receptors</article-title><source>Nat Immunol</source><year>2003</year><volume>4</volume><fpage>801</fpage><lpage>807</lpage><pub-id pub-id-type="pmid">12858173</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlyle</surname><given-names>JR</given-names></name><name><surname>Jamieson</surname><given-names>AM</given-names></name><name><surname>Gasser</surname><given-names>S</given-names></name><name><surname>Clingan</surname><given-names>CS</given-names></name><name><surname>Arase</surname><given-names>H</given-names></name><name><surname>Raulet</surname><given-names>DH</given-names></name></person-group><article-title>Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors</article-title><source>Proc Natl Acad Sci U S A</source><year>2004</year><volume>101</volume><fpage>3527</fpage><lpage>3532</lpage><pub-id pub-id-type="pmid">14990792</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aldemir</surname><given-names>H</given-names></name><name><surname>Prod'homme</surname><given-names>V</given-names></name><name><surname>Dumaurier</surname><given-names>MJ</given-names></name><name><surname>Retiere</surname><given-names>C</given-names></name><name><surname>Poupon</surname><given-names>G</given-names></name><name><surname>Cazareth</surname><given-names>J</given-names></name><etal/></person-group><article-title>Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor</article-title><source>J Immunol</source><year>2005</year><volume>175</volume><fpage>7791</fpage><lpage>7795</lpage><pub-id pub-id-type="pmid">16339512</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benlagha</surname><given-names>K</given-names></name><name><surname>Weiss</surname><given-names>A</given-names></name><name><surname>Beavis</surname><given-names>A</given-names></name><name><surname>Teyton</surname><given-names>L</given-names></name><name><surname>Bendelac</surname><given-names>A</given-names></name></person-group><article-title><italic>In vivo</italic> identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers</article-title><source>J Exp Med</source><year>2000</year><volume>191</volume><fpage>1895</fpage><lpage>1903</lpage><pub-id pub-id-type="pmid">10839805</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>JL</given-names></name><name><surname>Naidenko</surname><given-names>OV</given-names></name><name><surname>Gapin</surname><given-names>L</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>CR</given-names></name><etal/></person-group><article-title>Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers</article-title><source>J Exp Med</source><year>2000</year><volume>192</volume><fpage>741</fpage><lpage>754</lpage><pub-id pub-id-type="pmid">10974039</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellicci</surname><given-names>DG</given-names></name><name><surname>Hammond</surname><given-names>KJ</given-names></name><name><surname>Uldrich</surname><given-names>AP</given-names></name><name><surname>Baxter</surname><given-names>AG</given-names></name><name><surname>Smyth</surname><given-names>MJ</given-names></name><name><surname>Godfrey</surname><given-names>DI</given-names></name></person-group><article-title>A Natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1<sup>-</sup>CD4<sup>+</sup> CD1d-dependent precursor stage</article-title><source>J Exp Med</source><year>2002</year><volume>195</volume><fpage>835</fpage><lpage>844</lpage><pub-id pub-id-type="pmid">11927628</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benlagha</surname><given-names>K</given-names></name><name><surname>Kyin</surname><given-names>T</given-names></name><name><surname>Beavis</surname><given-names>A</given-names></name><name><surname>Teyton</surname><given-names>L</given-names></name><name><surname>Bendelac</surname><given-names>A</given-names></name></person-group><article-title>A thymic precursor to the NK T cell lineage</article-title><source>Science</source><year>2002</year><volume>296</volume><fpage>553</fpage><lpage>555</lpage><pub-id pub-id-type="pmid">11968185</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emoto</surname><given-names>M</given-names></name><name><surname>Emoto</surname><given-names>Y</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><article-title>Bacille Calmette Gu&#x000e9;rin and interleukin-12 down-modulate interleukin-4-producing CD4<sup>+</sup>NK1<sup>+</sup> T lymphocytes</article-title><source>Eur J Immunol</source><year>1997</year><volume>27</volume><fpage>183</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">9022016</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emoto</surname><given-names>Y</given-names></name><name><surname>Emoto</surname><given-names>M</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><article-title>Transient control of interleukin-4-producing natural killer T cells in the livers of <italic>Listeria monocytogenes</italic>-infected mice by interleukin-12</article-title><source>Infect Immun</source><year>1997</year><volume>65</volume><fpage>5003</fpage><lpage>5009</lpage><pub-id pub-id-type="pmid">9393789</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Paul</surname><given-names>WE</given-names></name></person-group><article-title>NK1.1<sup>+</sup> CD4<sup>+</sup> T cells lose NK11 expression upon <italic>in vitro</italic> activation</article-title><source>J Immunol</source><year>1997</year><volume>158</volume><fpage>5112</fpage><lpage>5119</lpage><pub-id pub-id-type="pmid">9164926</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eberl</surname><given-names>G</given-names></name><name><surname>MacDonald</surname><given-names>HR</given-names></name></person-group><article-title>Rapid death and regeneration of NKT cells in anti-CD3&#x003b5;- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis</article-title><source>Immunity</source><year>1998</year><volume>9</volume><fpage>345</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">9768754</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eberl</surname><given-names>G</given-names></name><name><surname>MacDonald</surname><given-names>HR</given-names></name></person-group><article-title>Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells</article-title><source>Eur J Immunol</source><year>2000</year><volume>30</volume><fpage>985</fpage><lpage>992</lpage><pub-id pub-id-type="pmid">10760785</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osman</surname><given-names>Y</given-names></name><name><surname>Kawamura</surname><given-names>T</given-names></name><name><surname>Naito</surname><given-names>T</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>van Kaer</surname><given-names>L</given-names></name><name><surname>Okumura</surname><given-names>K</given-names></name><etal/></person-group><article-title>Activation of hepatic NKT cells and subsequent liver injury following administration of &#x003b1;-galactosylceramide</article-title><source>Eur J Immunol</source><year>2000</year><volume>30</volume><fpage>1919</fpage><lpage>1928</lpage><pub-id pub-id-type="pmid">10940881</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leite-de-Moraes</surname><given-names>MC</given-names></name><name><surname>Herbelin</surname><given-names>A</given-names></name><name><surname>Gouarin</surname><given-names>C</given-names></name><name><surname>Koezuka</surname><given-names>Y</given-names></name><name><surname>Schneider</surname><given-names>E</given-names></name><name><surname>Dy</surname><given-names>M</given-names></name></person-group><article-title>Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes</article-title><source>J Immunol</source><year>2000</year><volume>165</volume><fpage>4367</fpage><lpage>4371</lpage><pub-id pub-id-type="pmid">11035073</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniels</surname><given-names>KA</given-names></name><name><surname>Devora</surname><given-names>G</given-names></name><name><surname>Lai</surname><given-names>WC</given-names></name><name><surname>O'Donnell</surname><given-names>CL</given-names></name><name><surname>Bennett</surname><given-names>M</given-names></name><name><surname>Welsh</surname><given-names>RM</given-names></name></person-group><article-title>Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H</article-title><source>J Exp Med</source><year>2001</year><volume>194</volume><fpage>29</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">11435470</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobbs</surname><given-names>JA</given-names></name><name><surname>Cho</surname><given-names>S</given-names></name><name><surname>Roberts</surname><given-names>TJ</given-names></name><name><surname>Sriram</surname><given-names>V</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus</article-title><source>J Virol</source><year>2001</year><volume>75</volume><fpage>10746</fpage><lpage>10754</lpage><pub-id pub-id-type="pmid">11602716</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujii</surname><given-names>S</given-names></name><name><surname>Shimizu</surname><given-names>K</given-names></name><name><surname>Kronenberg</surname><given-names>M</given-names></name><name><surname>Steinman</surname><given-names>RM</given-names></name></person-group><article-title>Prolonged IFN-&#x003b3;-producing NKT response induced with &#x003b1;-galactosylceramide-loaded DCs</article-title><source>Nat Immunol</source><year>2002</year><volume>3</volume><fpage>867</fpage><lpage>874</lpage><pub-id pub-id-type="pmid">12154358</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirby</surname><given-names>AC</given-names></name><name><surname>Yrlid</surname><given-names>U</given-names></name><name><surname>Wick</surname><given-names>MJ</given-names></name></person-group><article-title>The innate immune response differs in primary and secondary <italic>Salmonella</italic> infection</article-title><source>J Immunol</source><year>2002</year><volume>169</volume><fpage>4450</fpage><lpage>4459</lpage><pub-id pub-id-type="pmid">12370380</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motsinger</surname><given-names>A</given-names></name><name><surname>Haas</surname><given-names>DW</given-names></name><name><surname>Stanic</surname><given-names>AK</given-names></name><name><surname>van Kaer</surname><given-names>L</given-names></name><name><surname>Joyce</surname><given-names>S</given-names></name><name><surname>Unutmaz</surname><given-names>D</given-names></name></person-group><article-title>CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection</article-title><source>J Exp Med</source><year>2002</year><volume>195</volume><fpage>869</fpage><lpage>879</lpage><pub-id pub-id-type="pmid">11927631</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crowe</surname><given-names>NY</given-names></name><name><surname>Uldrich</surname><given-names>AP</given-names></name><name><surname>Kyparissoudis</surname><given-names>K</given-names></name><name><surname>Hammond</surname><given-names>KJ</given-names></name><name><surname>Hayakawa</surname><given-names>Y</given-names></name><name><surname>Sidobre</surname><given-names>S</given-names></name><etal/></person-group><article-title>Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells</article-title><source>J Immunol</source><year>2003</year><volume>171</volume><fpage>4020</fpage><lpage>4027</lpage><pub-id pub-id-type="pmid">14530322</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>MT</given-names></name><name><surname>Johansson</surname><given-names>C</given-names></name><name><surname>Olivares-Villag&#x000f3;mez</surname><given-names>D</given-names></name><name><surname>Singh</surname><given-names>AK</given-names></name><name><surname>Stanic</surname><given-names>AK</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><etal/></person-group><article-title>The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion</article-title><source>Proc Natl Acad Sci U S A</source><year>2003</year><volume>100</volume><fpage>10913</fpage><lpage>10918</lpage><pub-id pub-id-type="pmid">12960397</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harada</surname><given-names>M</given-names></name><name><surname>Seino</surname><given-names>K</given-names></name><name><surname>Wakao</surname><given-names>H</given-names></name><name><surname>Sakata</surname><given-names>S</given-names></name><name><surname>Ishizuka</surname><given-names>Y</given-names></name><name><surname>Ito</surname><given-names>T</given-names></name><etal/></person-group><article-title>Down-regulation of the invariant V&#x003b1;14 antigen receptor in NKT cells upon activation</article-title><source>Int Immunol</source><year>2004</year><volume>16</volume><fpage>241</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">14734609</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berntman</surname><given-names>E</given-names></name><name><surname>Rolf</surname><given-names>J</given-names></name><name><surname>Johansson</surname><given-names>C</given-names></name><name><surname>Anderson</surname><given-names>P</given-names></name><name><surname>Cardell</surname><given-names>SL</given-names></name></person-group><article-title>The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with <italic>Salmonella typhimurium</italic></article-title><source>Eur J Immunol</source><year>2005</year><volume>35</volume><fpage>2100</fpage><lpage>2109</lpage><pub-id pub-id-type="pmid">15940666</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Roberts</surname><given-names>TJ</given-names></name><name><surname>Wang</surname><given-names>CR</given-names></name><name><surname>Cho</surname><given-names>S</given-names></name><name><surname>Brutkiewicz</surname><given-names>RR</given-names></name></person-group><article-title>Long-term loss of canonical NKT cells following an acute virus infection</article-title><source>Eur J Immunol</source><year>2005</year><volume>35</volume><fpage>879</fpage><lpage>889</lpage><pub-id pub-id-type="pmid">15724241</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinchieri</surname><given-names>G</given-names></name></person-group><article-title>Interleukin-12 and the regulation of innate resistance and adaptive immunity</article-title><source>Nat Rev Immunol</source><year>2003</year><volume>3</volume><fpage>133</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">12563297</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripp</surname><given-names>CS</given-names></name><name><surname>Gately</surname><given-names>MK</given-names></name><name><surname>Hakimi</surname><given-names>J</given-names></name><name><surname>Ling</surname><given-names>P</given-names></name><name><surname>Unanue</surname><given-names>ER</given-names></name></person-group><article-title>Neutralization of IL-12 decreases resistance to <italic>Listeria</italic> in SCID and C.B-17 mice. Reversal by IFN-&#x003b3;</article-title><source>J Immunol</source><year>1994</year><volume>152</volume><fpage>1883</fpage><lpage>1887</lpage><pub-id pub-id-type="pmid">7907107</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emoto</surname><given-names>M</given-names></name><name><surname>Yoshizawa</surname><given-names>I</given-names></name><name><surname>Emoto</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Hurwitz</surname><given-names>R</given-names></name><name><surname>Miamoto</surname><given-names>M</given-names></name><etal/></person-group><article-title>Reversible NK1.1 surface expression by invariant liver natural killer T cells during <italic>Listeria monocytogenes</italic> infection</article-title><source>Microbes Infect</source><year>2007</year><volume>9</volume><fpage>1511</fpage><lpage>1520</lpage><pub-id pub-id-type="pmid">18024119</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emoto</surname><given-names>Y</given-names></name><name><surname>Yoshizawa</surname><given-names>I</given-names></name><name><surname>Hurwitz</surname><given-names>R</given-names></name><name><surname>Brinkmann</surname><given-names>V</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name><name><surname>Emoto</surname><given-names>M</given-names></name></person-group><article-title>Role of interleukin-12 in determining differential kinetics of invariant natural killer T cells in response to differential burden of <italic>Listeria monocytogenes</italic></article-title><source>Microbes Infect</source><year>2008</year><volume>10</volume><fpage>224</fpage><lpage>232</lpage><pub-id pub-id-type="pmid">18321748</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oppmann</surname><given-names>B</given-names></name><name><surname>Lesley</surname><given-names>R</given-names></name><name><surname>Blom</surname><given-names>B</given-names></name><name><surname>Timans</surname><given-names>JC</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Hunte</surname><given-names>B</given-names></name><etal/></person-group><article-title>Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12</article-title><source>Immunity</source><year>2000</year><volume>13</volume><fpage>715</fpage><lpage>725</lpage><pub-id pub-id-type="pmid">11114383</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eberl</surname><given-names>G</given-names></name><name><surname>Lees</surname><given-names>R</given-names></name><name><surname>Smiley</surname><given-names>ST</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Grusby</surname><given-names>MJ</given-names></name><name><surname>MacDonald</surname><given-names>HR</given-names></name></person-group><article-title>Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells</article-title><source>J Immunol</source><year>1999</year><volume>162</volume><fpage>6410</fpage><lpage>6419</lpage><pub-id pub-id-type="pmid">10352254</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Legendre</surname><given-names>V</given-names></name><name><surname>Boyer</surname><given-names>C</given-names></name><name><surname>Guerder</surname><given-names>S</given-names></name><name><surname>Arnold</surname><given-names>B</given-names></name><name><surname>H&#x000e4;mmerling</surname><given-names>G</given-names></name><name><surname>Schmitt-Verhulst</surname><given-names>AM</given-names></name></person-group><article-title>Selection of phenotypically distinct NK1.1<sup>+</sup> T cells upon antigen expression in the thymus or in the liver</article-title><source>Eur J Immunol</source><year>1999</year><volume>29</volume><fpage>2330</fpage><lpage>2343</lpage><pub-id pub-id-type="pmid">10427996</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammond</surname><given-names>KJ</given-names></name><name><surname>Pelikan</surname><given-names>SB</given-names></name><name><surname>Crowe</surname><given-names>NY</given-names></name><name><surname>Randle-Barrett</surname><given-names>E</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><etal/></person-group><article-title>NKT cells are phenotypically and functionally diverse</article-title><source>Eur J Immunol</source><year>1999</year><volume>29</volume><fpage>3768</fpage><lpage>3781</lpage><pub-id pub-id-type="pmid">10556834</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emoto</surname><given-names>M</given-names></name><name><surname>Zerrahn</surname><given-names>J</given-names></name><name><surname>Miyamoto</surname><given-names>M</given-names></name><name><surname>P&#x000e9;rarnau</surname><given-names>B</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><article-title>Phenotypic characterization of CD8<sup>+</sup>NKT cells</article-title><source>Eur J Immunol</source><year>2000</year><volume>30</volume><fpage>2300</fpage><lpage>2311</lpage><pub-id pub-id-type="pmid">10940921</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coles</surname><given-names>MC</given-names></name><name><surname>McMahon</surname><given-names>CW</given-names></name><name><surname>Takizawa</surname><given-names>H</given-names></name><name><surname>Raulet</surname><given-names>DH</given-names></name></person-group><article-title>Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors</article-title><source>Eur J Immunol</source><year>2000</year><volume>30</volume><fpage>236</fpage><lpage>244</lpage><pub-id pub-id-type="pmid">10602046</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koyasu</surname><given-names>S</given-names></name></person-group><article-title>CD3<sup>+</sup>CD16<sup>+</sup>NK1.1<sup>+</sup>B220<sup>+</sup> large granular lymphocytes arise from both &#x003b1;-&#x003b2;TCR<sup>+</sup>CD4<sup>-</sup>CD8<sup>-</sup> and &#x003b3;-&#x003b4; TCR<sup>+</sup>CD4<sup>-</sup>CD8<sup>-</sup>cells</article-title><source>J Exp Med</source><year>1994</year><volume>179</volume><fpage>1957</fpage><lpage>1972</lpage><pub-id pub-id-type="pmid">8195719</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arase</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>S</given-names></name><name><surname>Arase</surname><given-names>N</given-names></name><name><surname>Park</surname><given-names>SY</given-names></name><name><surname>Wakizaka</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><etal/></person-group><article-title>Developmental arrest of NK1.1<sup>+</sup> T cell antigen receptor (TCR)-&#x003b1;/&#x003b2;<sup>+</sup> T cells and expansion of NK1.1<sup>+</sup> TCR-&#x003b3;/&#x003b4;<sup>+</sup> T cell development in CD3&#x003b6;-deficient mice</article-title><source>J Exp Med</source><year>1995</year><volume>182</volume><fpage>891</fpage><lpage>895</lpage><pub-id pub-id-type="pmid">7650493</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vicari</surname><given-names>AP</given-names></name><name><surname>Mocci</surname><given-names>S</given-names></name><name><surname>Openshaw</surname><given-names>P</given-names></name><name><surname>O'Garra</surname><given-names>A</given-names></name><name><surname>Zlotnik</surname><given-names>A</given-names></name></person-group><article-title>Mouse &#x003b3;&#x003b4; TCR<sup>+</sup>NK1.1<sup>+</sup> thymocytes specifically produce interleukin-4, are major histocompatibility complex class I independent, and are developmentally related to &#x003b1;&#x003b2; TCR<sup>+</sup>NK1.1<sup>+</sup> thymocytes</article-title><source>Eur J Immunol</source><year>1996</year><volume>26</volume><fpage>1424</fpage><lpage>1429</lpage><pub-id pub-id-type="pmid">8766542</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emoto</surname><given-names>M</given-names></name><name><surname>Miyamoto</surname><given-names>M</given-names></name><name><surname>Emoto</surname><given-names>Y</given-names></name><name><surname>Zerrahn</surname><given-names>J</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><article-title>A critical role of T-cell receptor &#x003b3;/&#x003b4; cells in antibacterial protection in mice early in life</article-title><source>Hepatology</source><year>2001</year><volume>33</volume><fpage>887</fpage><lpage>893</lpage><pub-id pub-id-type="pmid">11283853</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>JL</given-names></name><name><surname>Gapin</surname><given-names>L</given-names></name><name><surname>Sidobre</surname><given-names>S</given-names></name><name><surname>Kieper</surname><given-names>WC</given-names></name><name><surname>Tan</surname><given-names>JT</given-names></name><name><surname>Ceredig</surname><given-names>R</given-names></name><etal/></person-group><article-title>Homeostasis of V&#x003b1;14i NKT cells</article-title><source>Nat Immunol</source><year>2002</year><volume>3</volume><fpage>966</fpage><lpage>974</lpage><pub-id pub-id-type="pmid">12244311</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranson</surname><given-names>T</given-names></name><name><surname>Vosshenrich</surname><given-names>CA</given-names></name><name><surname>Corcuff</surname><given-names>E</given-names></name><name><surname>Richard</surname><given-names>O</given-names></name><name><surname>Laloux</surname><given-names>V</given-names></name><name><surname>Lehuen</surname><given-names>A</given-names></name><etal/></person-group><article-title>IL-15 availability conditions homeostasis of peripheral natural killer T cells</article-title><source>Proc Natl Acad Sci U S A</source><year>2003</year><volume>100</volume><fpage>2663</fpage><lpage>2668</lpage><pub-id pub-id-type="pmid">12598649</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohteki</surname><given-names>T</given-names></name><name><surname>Ho</surname><given-names>S</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Mak</surname><given-names>TW</given-names></name><name><surname>Ohashi</surname><given-names>PS</given-names></name></person-group><article-title>Role for IL-15/IL-15 receptor &#x003b2;-chain in natural killer 1.1<sup>+</sup> T cell receptor-&#x003b1;&#x003b2;<sup>+</sup> cell development</article-title><source>J Immunol</source><year>1997</year><volume>159</volume><fpage>5931</fpage><lpage>5935</lpage><pub-id pub-id-type="pmid">9550390</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bendelac</surname><given-names>A</given-names></name></person-group><article-title>Positive selection of mouse NK1<sup>+</sup> T cells by CD1-expressing cortical thymocytes</article-title><source>J Exp Med</source><year>1995</year><volume>182</volume><fpage>2091</fpage><lpage>2096</lpage><pub-id pub-id-type="pmid">7500054</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammond</surname><given-names>K</given-names></name><name><surname>Cain</surname><given-names>W</given-names></name><name><surname>van Driel</surname><given-names>I</given-names></name><name><surname>Godfrey</surname><given-names>D</given-names></name></person-group><article-title>Three day neonatal thymectomy selectively depletes NK1.1<sup>+</sup> T cells</article-title><source>Int Immunol</source><year>1998</year><volume>10</volume><fpage>1491</fpage><lpage>1499</lpage><pub-id pub-id-type="pmid">9796916</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tilloy</surname><given-names>F</given-names></name><name><surname>Di Santo</surname><given-names>JP</given-names></name><name><surname>Bendelac</surname><given-names>A</given-names></name><name><surname>Lantz</surname><given-names>O</given-names></name></person-group><article-title>Thymic dependence of invariant V&#x003b1;14<sup>+</sup> natural killer-T cell development</article-title><source>Eur J Immunol</source><year>1999</year><volume>29</volume><fpage>3313</fpage><lpage>3318</lpage><pub-id pub-id-type="pmid">10540343</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kameyama</surname><given-names>H</given-names></name><name><surname>Kawamura</surname><given-names>T</given-names></name><name><surname>Naito</surname><given-names>T</given-names></name><name><surname>Bannai</surname><given-names>M</given-names></name><name><surname>Shimamura</surname><given-names>K</given-names></name><name><surname>Hatakeyama</surname><given-names>K</given-names></name><etal/></person-group><article-title>Size of the population of CD4<sup>+</sup> natural killer T cells in the liver is maintained without supply by the thymus during adult life</article-title><source>Immunology</source><year>2001</year><volume>104</volume><fpage>135</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">11683952</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bendelac</surname><given-names>A</given-names></name><name><surname>Rivera</surname><given-names>MN</given-names></name><name><surname>Park</surname><given-names>SH</given-names></name><name><surname>Roark</surname><given-names>JH</given-names></name></person-group><article-title>Mouse CD1-specific NK1 T cells: development, specificity, and function</article-title><source>Annu Rev Immunol</source><year>1997</year><volume>15</volume><fpage>535</fpage><lpage>562</lpage><pub-id pub-id-type="pmid">9143699</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davodeau</surname><given-names>F</given-names></name><name><surname>Peyrat</surname><given-names>MA</given-names></name><name><surname>Necker</surname><given-names>A</given-names></name><name><surname>Dominici</surname><given-names>R</given-names></name><name><surname>Blanchard</surname><given-names>F</given-names></name><name><surname>Leget</surname><given-names>C</given-names></name><etal/></person-group><article-title>Close phenotypic and functional similarities between human and murine &#x003b1;&#x003b2; T cells expressing invariant TCR &#x003b1;-chains</article-title><source>J Immunol</source><year>1997</year><volume>158</volume><fpage>5603</fpage><lpage>5611</lpage><pub-id pub-id-type="pmid">9190907</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hameg</surname><given-names>A</given-names></name><name><surname>Apostolou</surname><given-names>I</given-names></name><name><surname>Leite-De-Moraes</surname><given-names>M</given-names></name><name><surname>Gombert</surname><given-names>JM</given-names></name><name><surname>Garcia</surname><given-names>C</given-names></name><name><surname>Koezuka</surname><given-names>Y</given-names></name><etal/></person-group><article-title>A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the &#x003b1;-galactosylceramide antigen</article-title><source>J Immunol</source><year>2000</year><volume>165</volume><fpage>4917</fpage><lpage>4926</lpage><pub-id pub-id-type="pmid">11046017</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Nieda</surname><given-names>M</given-names></name><name><surname>Koezuka</surname><given-names>Y</given-names></name><name><surname>Nicol</surname><given-names>A</given-names></name><name><surname>Porcelli</surname><given-names>SA</given-names></name><name><surname>Ishikawa</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Analysis of human V&#x003b1;24<sup>+</sup>CD4<sup>+</sup> NKT cells activated by &#x003b1;-glycosylceramide-pulsed monocyte-derived dendritic cells</article-title><source>J Immunol</source><year>2000</year><volume>164</volume><fpage>4458</fpage><lpage>4464</lpage><pub-id pub-id-type="pmid">10779745</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gumperz</surname><given-names>JE</given-names></name><name><surname>Miyake</surname><given-names>S</given-names></name><name><surname>Yamamura</surname><given-names>T</given-names></name><name><surname>Brenner</surname><given-names>MB</given-names></name></person-group><article-title>Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining</article-title><source>J Exp Med</source><year>2002</year><volume>195</volume><fpage>625</fpage><lpage>636</lpage><pub-id pub-id-type="pmid">11877485</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>PT</given-names></name><name><surname>Benlagha</surname><given-names>K</given-names></name><name><surname>Teyton</surname><given-names>L</given-names></name><name><surname>Bendelac</surname><given-names>A</given-names></name></person-group><article-title>Distinct functional lineages of human V&#x003b1;24 natural killer T cells</article-title><source>J Exp Med</source><year>2002</year><volume>195</volume><fpage>637</fpage><lpage>641</lpage><pub-id pub-id-type="pmid">11877486</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>JL</given-names></name><name><surname>Gapin</surname><given-names>L</given-names></name><name><surname>Baron</surname><given-names>JL</given-names></name><name><surname>Sidobre</surname><given-names>S</given-names></name><name><surname>Stetson</surname><given-names>DB</given-names></name><name><surname>Mohrs</surname><given-names>M</given-names></name><etal/></person-group><article-title>Mouse V&#x003b1;14i natural killer T cells are resistant to cytokine polarization <italic>in vivo</italic></article-title><source>Proc Natl Acad Sci U S A</source><year>2003</year><volume>100</volume><fpage>8395</fpage><lpage>8400</lpage><pub-id pub-id-type="pmid">12829795</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stetson</surname><given-names>DB</given-names></name><name><surname>Mohrs</surname><given-names>M</given-names></name><name><surname>Reinhardt</surname><given-names>RL</given-names></name><name><surname>Baron</surname><given-names>JL</given-names></name><name><surname>Wang</surname><given-names>ZE</given-names></name><name><surname>Gapin</surname><given-names>L</given-names></name><etal/></person-group><article-title>Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function</article-title><source>J Exp Med</source><year>2003</year><volume>198</volume><fpage>1069</fpage><lpage>1076</lpage><pub-id pub-id-type="pmid">14530376</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plougastel</surname><given-names>B</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name><name><surname>Dubbelde</surname><given-names>C</given-names></name><name><surname>Yokoyama</surname><given-names>WM</given-names></name></person-group><article-title>Analysis of a 1-Mb BAC contig overlapping the mouse Nkrp1 cluster of genes: cloning of three new Nkrp1 members, Nkrp1d, Nkrp1e, and Nkrp1f</article-title><source>Immunogenetics</source><year>2001</year><volume>53</volume><fpage>592</fpage><lpage>598</lpage><pub-id pub-id-type="pmid">11685472</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmberg</surname><given-names>LA</given-names></name><name><surname>Ault</surname><given-names>KA</given-names></name></person-group><article-title>Characterization of <italic>Listeria monocytogenes</italic>-induced murine natural killer cells</article-title><source>Immunol Res</source><year>1986</year><volume>5</volume><fpage>50</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">3093607</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bancroft</surname><given-names>GJ</given-names></name><name><surname>Schreiber</surname><given-names>RD</given-names></name><name><surname>Unanue</surname><given-names>ER</given-names></name></person-group><article-title>Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse</article-title><source>Immunol Rev</source><year>1991</year><volume>124</volume><fpage>5</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">1804781</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Hendriks</surname><given-names>W</given-names></name><name><surname>Althage</surname><given-names>A</given-names></name><name><surname>Hemmi</surname><given-names>S</given-names></name><name><surname>Bluethmann</surname><given-names>H</given-names></name><name><surname>Kamijo</surname><given-names>R</given-names></name><etal/></person-group><article-title>Immune response in mice that lack the interferon-&#x003b3; receptor</article-title><source>Science</source><year>1993</year><volume>259</volume><fpage>1742</fpage><lpage>1745</lpage><pub-id pub-id-type="pmid">8456301</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harty</surname><given-names>JT</given-names></name><name><surname>Bevan</surname><given-names>MJ</given-names></name></person-group><article-title>Specific immunity to <italic>Listeria monocytogenes</italic> in the absence of IFN &#x003b3;</article-title><source>Immunity</source><year>1995</year><volume>3</volume><fpage>109</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">7621071</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iizawa</surname><given-names>Y</given-names></name><name><surname>Czuprynski</surname><given-names>C</given-names></name></person-group><article-title>Effects of administration of murine recombinant IL-4 on the resistance of mice to <italic>Listeria monocytogenes</italic> infection</article-title><source>Immunol Lett</source><year>1992</year><volume>32</volume><fpage>185</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">1612642</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haak-Frendscho</surname><given-names>M</given-names></name><name><surname>Brown</surname><given-names>JF</given-names></name><name><surname>Iizawa</surname><given-names>Y</given-names></name><name><surname>Wagner</surname><given-names>RD</given-names></name><name><surname>Czuprynski</surname><given-names>CJ</given-names></name></person-group><article-title>Administration of anti-IL-4 monoclonal antibody 11B11 increases the resistance of mice to <italic>Listeria monocytogenes</italic> infection</article-title><source>J Immunol</source><year>1992</year><volume>148</volume><fpage>3978</fpage><lpage>3985</lpage><pub-id pub-id-type="pmid">1602140</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szalay</surname><given-names>G</given-names></name><name><surname>Ladel</surname><given-names>CH</given-names></name><name><surname>Blum</surname><given-names>C</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><article-title>IL-4 neutralization or TNF-&#x003b3; treatment ameliorate disease by an intracellular pathogen in IFN-&#x003b3; receptor-deficient mice</article-title><source>J Immunol</source><year>1996</year><volume>157</volume><fpage>4746</fpage><lpage>4750</lpage><pub-id pub-id-type="pmid">8943375</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>SH</given-names></name><name><surname>Emoto</surname><given-names>M</given-names></name><name><surname>Szalay</surname><given-names>G</given-names></name><name><surname>Barsig</surname><given-names>J</given-names></name><name><surname>Flesch</surname><given-names>IE</given-names></name></person-group><article-title>Interleukin-4 and listeriosis</article-title><source>Immunol Rev</source><year>1997</year><volume>158</volume><fpage>95</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">9314077</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranson</surname><given-names>T</given-names></name><name><surname>Bregenholt</surname><given-names>S</given-names></name><name><surname>Lehuen</surname><given-names>A</given-names></name><name><surname>Gaillot</surname><given-names>O</given-names></name><name><surname>Leite-de-Moraes</surname><given-names>MC</given-names></name><name><surname>Herbelin</surname><given-names>A</given-names></name><etal/></person-group><article-title>Invariant V&#x003b1;14<sup>+</sup> NKT cells participate in the early response to enteric <italic>Listeria monocytogenes</italic> infection</article-title><source>J Immunol</source><year>2005</year><volume>175</volume><fpage>1137</fpage><lpage>1144</lpage><pub-id pub-id-type="pmid">16002715</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. 1</label><caption><p>Course of intracellular bacteria following systemic infection.</p></caption><graphic xlink:href="ymj-50-12-g001"/></fig><fig id="F2" position="float"><label>Fig. 2</label><caption><p>Course of iNKT cells following &#x003b1;-GalCer stimulation or <italic>L. monocytogenes</italic> infection (A) &#x003b1;-GalCer stimulation; (B) <italic>L. monocytogenes</italic> infection.</p></caption><graphic xlink:href="ymj-50-12-g002"/></fig><fig id="F3" position="float"><label>Fig. 3</label><caption><p>Accumulation of iNKT cells under physiological and inflammatory conditions.</p></caption><graphic xlink:href="ymj-50-12-g003"/></fig><fig id="F4" position="float"><label>Fig. 4</label><caption><p>Cytokine profile of CD4<sup>+</sup> and DN iNKT cells following <italic>L. monocytogenes</italic> infection.</p></caption><graphic xlink:href="ymj-50-12-g004"/></fig><fig id="F5" position="float"><label>Fig. 5</label><caption><p>NKR-P1 as a "missing-self" recognition molecule.</p></caption><graphic xlink:href="ymj-50-12-g005"/></fig></floats-group></article>